Related content

Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma

By Yung Raymond   Seyfoddin Vahid   Guise Christopher   Tijono Sofian   McGregor Ailsa   Connor Bronwen   Ching Lai-Ming  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhou Shufeng   Kestell Philip   Tingle Malcolm   Paxton James  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 126-132

Springer Publishing Company

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite

Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 20, Iss. 4, 2004-06 ,pp. : 393-404

Informa Healthcare

Access to resources Recommend Favorite

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

By Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 306-316

Informa Healthcare

Access to resources Recommend Favorite